An updated review of SARS-CoV-2 vaccines and the importance of effective vaccination programs in pandemic times
C García-Montero, O Fraile-Martínez, C Bravo… - Vaccines, 2021 - mdpi.com
Since the worldwide COVID-19 pandemic was declared a year ago, the search for vaccines
has become the top priority in order to restore normalcy after 2.5 million deaths worldwide …
has become the top priority in order to restore normalcy after 2.5 million deaths worldwide …
Vaccination and immunotherapies in neuroimmunological diseases
A Winkelmann, M Loebermann, M Barnett… - Nature Reviews …, 2022 - nature.com
Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …
A multi-echelon dynamic cold chain for managing vaccine distribution
VK Manupati, T Schoenherr, N Subramanian… - … Research Part E …, 2021 - Elsevier
While cold chain management has been part of healthcare systems, enabling the efficient
administration of vaccines in both urban and rural areas, the COVID-19 virus has created …
administration of vaccines in both urban and rural areas, the COVID-19 virus has created …
No effect of inactivated SARS-CoV-2 vaccination on in vitro fertilization outcomes: a propensity score-matched study
J Huang, L Xia, J Lin, B Liu, Y Zhao, C Xin… - Journal of …, 2022 - Taylor & Francis
Purpose To investigate the impact of inactivated SARS-CoV-2 vaccination on in vitro
fertilization (IVF) outcomes. Patients and Methods This retrospective cohort study included …
fertilization (IVF) outcomes. Patients and Methods This retrospective cohort study included …
A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
N Tokunoh, S Tamiya, M Watanabe… - Frontiers in …, 2023 - frontiersin.org
Introduction Vaccinations are ideal for reducing the severity of clinical manifestations and
secondary complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
secondary complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
Updated living systematic review and meta-analysis of controlled trials of mesenchymal stromal cells to treat COVID-19: a Framework for Accelerated Synthesis of Trial …
AM Kirkham, AJM Bailey, M Monaghan… - Stem cells …, 2022 - academic.oup.com
Abstract Background Mesenchymal stromal cells (MSCs) may reduce mortality in patients
with COVID-19; however, early evidence is based on few studies with marked interstudy …
with COVID-19; however, early evidence is based on few studies with marked interstudy …
A third dose of an inactivated vaccine dramatically increased the levels and decay times of anti-SARS-CoV-2 antibodies, but disappointingly declined again: a …
XM Liang, QY Xu, ZJ Jia, MJ Wu, YY Liu… - Frontiers in …, 2022 - frontiersin.org
Background Due to anti-SARS-CoV-2 antibody decay and SARS-CoV-2 variants, vaccine
booster doses are a constant concern. It was focused on whether the third dose can quickly …
booster doses are a constant concern. It was focused on whether the third dose can quickly …
Large‐sized graphene oxide nanosheets increase DC–T‐cell synaptic contact and the efficacy of DC vaccines against SARS‐CoV‐2
Q Zhou, H Gu, S Sun, Y Zhang, Y Hou, C Li… - Advanced …, 2021 - Wiley Online Library
Dendritic cell (DC) vaccines are used for cancer and infectious diseases, albeit with limited
efficacy. Modulating the formation of DC–T‐cell synapses may greatly increase their efficacy …
efficacy. Modulating the formation of DC–T‐cell synapses may greatly increase their efficacy …
Response and duration of serum anti-SARS-CoV-2 antibodies after inactivated vaccination within 160 days
QY Xu, JH Xue, Y Xiao, ZJ Jia, MJ Wu, YY Liu… - Frontiers in …, 2021 - frontiersin.org
Background A vaccine against coronavirus disease 2019 (COVID-19) with highly effective
protection is urgently needed. The anti-severe acute respiratory syndrome coronavirus 2 …
protection is urgently needed. The anti-severe acute respiratory syndrome coronavirus 2 …
Efficacy and safety of COVID-19 vaccines in phase III trials: a meta-analysis
H Cheng, Z Peng, W Luo, S Si, M Mo, H Zhou, X Xin… - Vaccines, 2021 - mdpi.com
Nowadays, the vaccination with COVID-19 vaccines is being promoted worldwide,
professionals and common people are very concerned about the efficacy and safety of …
professionals and common people are very concerned about the efficacy and safety of …